Migraine/Headache Clinical Research Trials

Coming Soon

A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ZOLMITRIPTAN NASAL SPRAY FOR THE TREATMENT OF ACUTE MIGRAINE IN SUBJECTS AGES 6 TO 11 YEARS, WITH AN OPEN-LABEL EXTENSION


Active

A Phase 2a Randomized Double-blind Placebo Controlled Study to Evaluate the Efficacy and Safety of AMG 301 in Migraine Prevention

  • Status:Enrolling
  • Sponsor: Amgen
  • Click here for more information

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AMG 334 in Chronic Migraine Prevention.

  • Status:Closed to Enrolling
  • Sponsor: Amgen
  • Click here for more information

A Multicenter, Prospective, Randomized, Open-label Study to Compare the Efficacy, Safety, and Tolerability of BOTOX® and Topiramate for Headache Prophylaxis in Adults with Chronic Migraine (GMA-US-NEU-0206).

  • Status:Closed to Enrolling
  • Sponsor: Allergan
  • Click here for more information